COVID-19 patients with DM have significantly higher inflammatory markers, such as interleukin 6 (IL-6), C-reactive protein (CRP), and neutrophil–lymphocyte ratio (NLR) than those without DM [16,30,31,32,33]. The gene discussed is IL6; the disease is diabetes mellitus.